Moody Aldrich Partners »

Ascendis Pharma AS shares owned by Moody Aldrich Partners

Quarter-by-quarter ownership of Ascendis Pharma AS (ASND) shares owned by Moody Aldrich Partners from 13F filings

Historical chart of Moody Aldrich Partners investment in Ascendis Pharma AS

Tip: Access up to 7 years of quarterly data

All positions including Ascendis Pharma AS held by Moody Aldrich Partners consolidated in one spreadsheet with up to 7 years of data

Download as csvDownload consolidated filings csv Download as ExcelDownload consolidated filings xlsx

Quarterly reported holdings in Ascendis Pharma AS by Moody Aldrich Partners

Quarter filed Position value Share count Share price at filing
2026-06-30 $332k 1.2k 266.72

More positions owned by Moody Aldrich Partners

Element Solutions (ESI)
Oruka Therapeutics (ORKA)
Independent Bank (INDB)
Wintrust Financial Corporation (WTFC)
Ligand Pharmaceuticals Com New (LGND)
Old National Ban (ONB)
Columbia Banking System (COLB)
Riot Blockchain (RIOT)
Meta Financial (CASH)
Core Scientific (CORZ)
Protagonist Therapeutics (PTGX)
Dianthus Therapeutics (DNTH)
Cipher Mining (CIFR)
Ambiq Micro Common Stock (AMBQ)
Hut 8 Corp (HUT)

View all positions for Moody Aldrich Partners

Top funds holding Ascendis Pharma AS

RA Capital Management
venBio Select Advisor
Westfield Capital Management Company
Jupiter Topco
FMR
Artisan Partners Limited Partnership
BlackRock
Capital Research and Management Company - Division 3
Massachusetts Financial Services
Franklin Resources
Wellington Management Company
T. Rowe Price Associates
American Century Companies
Perceptive Advisors
Principal Financial Group

View all funds holding Ascendis Pharma AS